These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A trial of live virus intra-nasal influenza vaccine. Dodge JS N Z Med J; 1978 Feb; 87(605):79-82. PubMed ID: 273801 [TBL] [Abstract][Full Text] [Related]
26. The experience of the "Stefan S. Nicolau" Institue of Virology in the preparation of administration of inactivated influenza vaccines applicable by nasal or oral route. Petrescu A; Cajal N; Broniţki A; Mihail A; Teodosiu O; Popescu G; Isaia G; Popescu A Virologie; 1977; 28(3):213-7. PubMed ID: 898654 [TBL] [Abstract][Full Text] [Related]
27. [Tolerance and immunogenicity of an attenuated live influenza virus vaccine in man (author's transl)]. Kuwert E; Höher PG; Fröcher R; Marcus I; Thraenhart O Dtsch Med Wochenschr; 1975 Dec; 100(52):2629-35. PubMed ID: 1204500 [TBL] [Abstract][Full Text] [Related]
28. ACIP releases recommendations for use of live, attenuated influenza vaccine. Ressel GW; Am Fam Physician; 2003 Dec; 68(11):2275-6. PubMed ID: 14677671 [No Abstract] [Full Text] [Related]
29. Epidemiological evaluation of the protection conferred by the Nivgrip vaccine against influenza caused by the A(H1N1) virus. Teodorovici G; Ivan A; Petrescu A; Mihail A; Cajal N Virologie; 1982; 33(4):279-82. PubMed ID: 7164342 [No Abstract] [Full Text] [Related]
30. [Experience with Czechoslovak subunit anti-influenza vaccine (author's transl)]. Závadová H; Vonka V; Stárek M; Domorázková E; Bruj J; Skocil V Cas Lek Cesk; 1975 Nov; 114(47):1462-6. PubMed ID: 1203931 [No Abstract] [Full Text] [Related]
31. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children. Piedra PA; Gaglani MJ; Kozinetz CA; Herschler GB; Fewlass C; Harvey D; Zimmerman N; Glezen WP Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577 [TBL] [Abstract][Full Text] [Related]
32. Benefits and risks of live attenuated influenza vaccine in young children. Oster G; Weycker D; Edelsberg J; Nichol KL; Klein JO; Belshe RB Am J Manag Care; 2010 Sep; 16(9):e235-44. PubMed ID: 21250400 [TBL] [Abstract][Full Text] [Related]
33. [Immunity and influenza virus]. Melino C Clin Ter; 1988 Sep; 126(5):353-62. PubMed ID: 2973965 [No Abstract] [Full Text] [Related]
34. A prospective, randomized, open-label trial comparing the safety and efficacy of trivalent live attenuated and inactivated influenza vaccines in adults 60 years of age and older. Forrest BD; Steele AD; Hiemstra L; Rappaport R; Ambrose CS; Gruber WC Vaccine; 2011 May; 29(20):3633-9. PubMed ID: 21440036 [TBL] [Abstract][Full Text] [Related]
35. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age. Block SL; Yogev R; Hayden FG; Ambrose CS; Zeng W; Walker RE Vaccine; 2008 Sep; 26(38):4940-6. PubMed ID: 18662737 [TBL] [Abstract][Full Text] [Related]
36. [Effectiveness of anti-influenza immunization and experience with peroral administration of live influenza vaccine]. Anisimova SA; Gol'denberg VA; Dudnik RM; Zakharchenko AA; Zil'ber AIa Vrach Delo; 1972 May; 5():139-42. PubMed ID: 5029784 [No Abstract] [Full Text] [Related]
37. [Epidemiological and economic evaluation of the effectiveness of immunization with live influenza vaccine during the influenza epidemic of 1971-1973 in the city of Frunze]. Zubareva LA; Evdoshenko VG; Turovskaia SI; Krivchemko EI; Shall' AIa Zdravookhr Kirg; 1976; (3):21-4. PubMed ID: 7895 [No Abstract] [Full Text] [Related]
38. Use of an inhibitor-resistant live attenuated influenza vaccine in normal and asthmatic adults. Warshauer DM; Minor TE; Inhorn SL; Reed CE; Dick EC Dev Biol Stand; 1976; 33():184-90. PubMed ID: 782967 [TBL] [Abstract][Full Text] [Related]
39. [Anti-influenza vaccination in children]. Battistini A; Ollari R; Dodi L Pediatr Med Chir; 1985; 7(3):369-74. PubMed ID: 3915545 [TBL] [Abstract][Full Text] [Related]